Household Transmission of Influenza (H1N1-2009) in Japan: Age-specificity and Reduction of Household Transmission Risk by Zanamivir Treatment

被引:37
作者
Nishiura, H. [1 ,2 ]
Oshitani, H. [3 ]
机构
[1] Univ Utrecht, NL-3584 CL Utrecht, Netherlands
[2] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan
基金
日本科学技术振兴机构;
关键词
INFLUENZA; H1N1-2009; EPIDEMIOLOGY; PANDEMIC; ANTIVIRAL DRUGS; NEURAMINIDASE INHIBITORS; PROPHYLAXIS; OSELTAMIVIR; ZANAMIVIR; A H1N1 VIRUS; PANDEMIC INFLUENZA; INFECTION; OSELTAMIVIR; INTERVAL; DISEASE; TRIALS;
D O I
10.1177/147323001103900231
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study investigated household transmission data for influenza (H1N1-2009) in Japan in order to quantify the age-specific risk of infection and estimate the impact of antiviral treatment on the risk of household transmission. Among a total of 1547 households, involving 4609 household contacts, the secondary attack ratio (SAR) was estimated to be 11.4%. School children aged 5 - 18 years dominated the index cases. Age-specific infectiousness and susceptibility were highest among 0 - 4-year olds, with SAR estimated at 19.4% and 29.6%, respectively. Zanamivir treatment within 24 and 24 - 48 h of illness onset in index cases, respectively, reduced the risk of household transmission to 0.57 (95% CI 0.44, 0.73) and 0.58 (95% CI 0.38, 0.86) times that among those receiving the same treatment at > 48 h and those not receiving treatment. The preventive performance of antiviral treatment and prophylaxis should be further examined in randomized controlled trials.
引用
收藏
页码:619 / 628
页数:10
相关论文
共 26 条
[21]   Travel and Age of Influenza A (H1N1) 2009 Virus Infection [J].
Nishiura, Hiroshi .
JOURNAL OF TRAVEL MEDICINE, 2010, 17 (04) :269-270
[23]   Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009 [J].
Nishiura, Hiroshi ;
Chowell, Gerardo ;
Safan, Muntaser ;
Castillo-Chavez, Carlos .
THEORETICAL BIOLOGY AND MEDICAL MODELLING, 2010, 7
[24]   Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? [J].
Reichert, Tom ;
Chowell, Gerardo ;
Nishiura, Hiroshi ;
Christensen, Ronald A. ;
McCullers, Jonathan A. .
BMC INFECTIOUS DISEASES, 2010, 10
[25]   Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials [J].
Shun-Shin, Matthew ;
Thompson, Matthew ;
Heneghan, Carl ;
Perera, Rafael ;
Harnden, Anthony ;
Mant, David .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :449
[26]  
Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738